Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-5942

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1 (Figr1)

A pharmacokinetic (PK) fold change chart showing the impact of various interacting drugs on venlafaxine and its metabolite ODV. It plots Cmax and AUC values relative to a reference, with corresponding clinical recommendations such as dose adjustments or cautions for drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figr2 (Figr2)

A forest plot chart depicting pharmacokinetic fold change (PKFold) and 90% confidence intervals (CI) for various interacting drugs with venlafaxine hydrochloride. The chart lists interacting drugs on the left, analytes including Cmax and AUC values in the middle, and corresponding dose adjustment recommendations on the right. The horizontal axis shows the fold change relative to a reference value from 0 to 3.*

FDA Label Image

Figr3 (Figr3)

A scatter plot chart showing fold changes and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC) of venlafaxine and its ODV metabolite across special populations. The populations include hepatic (cirrhosis, mild, moderate, mild/moderate impairment), renal (hemodialysis), CYP2D6 polymorphism, age over 60, and gender. Recommendations for dose adjustments are listed for hepatic and renal populations, while no dose adjustment is noted for CYP2D6 polymorphism, age, and gender groups.*

FDA Label Image

Label Image (Lbl500905942)

Venlafaxine Hydrochloride 37.5 mg extended-release capsules packaging label from A-S Medication Solutions. The label displays the product name, strength, dosage form, storage instructions to store at 68 to 77 degrees Fahrenheit, and package count of 30 capsules. The label includes the NDC 50090-5942-0 and routing as oral use only.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride, showing its molecular configuration with a chiral center, including functional groups such as methoxy, hydroxyl, and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.